Adverse events for Hemlibra▼, RoActemra and Alecensa▼ should be reported to Roche Products Ltd. Please contact Roche drug safety centre by emailing Roche. Hemlibra and RoActemra are biological medicines, Healthcare Professionals should report adverse reactions by brand name and batch number.
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See yellowcard.mhra.gov.uk for how to report side effects.
To report an adverse reaction please click here for further information on how to report and reporting details for Chugai and Roche products.